Long Term Study of Canakinumab (ACZ885) in Patients With Gout

Clinical trial NCT00927810 · COMPLETED

Trial details

NCT number: NCT00927810
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gouty Arthritis

Start date: 2009-06-05
Primary completion: 2010-08-04
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.